RenovoRx Joins Stanford-Backed StartX Med Program

RenovoRx, a leading developer of innovative solutions for targeted delivery of therapeutics to selected sites in the peripheral vascular system, today announced that the company was selected by the Stanford-affiliated StartX Med program for its Fall 2015 session. StartX is an educational non-profit organization that accelerates the development of Stanford’s top entrepreneurs through experiential education and collective intelligence. Specifically, StartX Med is a medical vertical of StartX focused on Stanford’s top medical entrepreneurs.

Read More